Benefits of combination antihypertensive therapy in progressive chronic renal failure

American Journal of Managed Care

Volumn 5, Issue 7 SUPPL., 1999, Pages

  Ifudu, Onyekachi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; SPIRONOLACTONE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIABETES MELLITUS; DIALYSIS; FLUID RETENTION; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033053847     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Obrador GT, Arora P, Kausz AT, et al. Preend-stage renal disease care in the United States: A state of disrepair. Am J Kidney Dis 1998;9:S44-S45.
2. US Renal Data System. USRDS 1996 Annual Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases;1998.
3. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996;28:841-845.
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
5. Peterson J, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: Modification of Diet in Renal Disease study. Ann Intern Med 1995;123:754-762.
6. Wright JT Jr, Kusek JW, Toto RD, et al. Design and baseline characteristics of participants in The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 1996;17:3S-16S.
7. UK Prospective Study Group. Tight blood glucose control and risk of macrovascular and microvascular complications in type II diabetes:UKPDS 38. BMJ 1998;317:703-713.
8. Bakris GL, Weir MR, DeQuattro V, McMahon FG. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria and diabetic nephrophathy. Kidney Int 1998;54:1283-1289.
9. Bakris GL. The role of combination antihypertensive therapy in the progression of renal disease from hypertension: Looking toward the next millennium. Am J Hypertens 1998;11(suppl):158-162.
10. Bakris GL, Weir MR. ACE inhibitor associated elevations in serum creatinine: Is this a cause for concern? Arch Intern Med [in press].
11. The Danish Study Group. Verapamil and myocardial infarction. Effect of verapamil on mortality and major events after acute myocardial infarction. Am J Cardiol 1990;66:779-785.